Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells

被引：0
作者：
L Li
A C Hung
A G Porter
机构：
[1] Cell Death and Human Disease Group,Division of Cancer and Developmental Cell Biology
[2] Institute of Molecular and Cell Biology,undefined
[3] A*STAR (Agency for Science,undefined
[4] Technology and Research),undefined
来源：
Cell Death & Differentiation | 2008年 / 15卷
关键词：
nitric oxide; apoptosis; AP-1; secretogranin; neuronal differentiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Identification of AP-1 target genes in apoptosis and differentiation has proved elusive. Secretogranin II (SgII) is a protein widely distributed in nervous and endocrine tissues, and abundant in neuroendocrine granules. We addressed whether SgII is regulated by AP-1, and if SgII is involved in neuronal differentiation or the cellular response to nitrosative stress. Nitric oxide (NO) upregulated sgII mRNA dependent on a cyclic AMP response element (CRE) in the sgII promoter, and NO stimulated SgII protein secretion in neuroblastoma cells. Upregulation of sgII mRNA, sgII CRE-driven gene expression and SgII protein synthesis/export were attenuated in cells transformed with dominant-negative c-Jun (TAM67), which became sensitized to NO-induced apoptosis and failed to undergo nerve growth factor-dependent neuronal differentiation. Stable transformation of TAM67 cells with sgII restored neuronal differentiation and resistance to NO. RNAi knockdown of sgII in cells expressing functional c-Jun abolished neuronal differentiation and rendered the cells sensitive to NO-induced apoptosis. Therefore, SgII represents a key AP-1-regulated protein that counteracts NO toxicity and mediates neuronal differentiation of neuroblastoma cells.
引用
收藏
页码：879 / 888
页数：9
相关论文
共 152 条
[21]  
Eiden LE(1997)Nitric oxide mediates intracytoplasmic and intranuclear zinc release FEBS Lett 405 37-41
[22]  
Anouar Y(2003)Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension Chest 123 869-874
[23]  
Mahata SK(1995)Nitric oxide donors: a continuing opportunity in drug design Adv Pharmacol 34 383-398
[24]  
Mahata M(2002)Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute Chest 122 2127-2136
[25]  
Livsey CV(2003) pneumonia Toxicol Appl Pharmacol 190 65-71
[26]  
Gerdes HH(2001)The safety of aerosolized diethylenetriamine nitric oxide adduct after single-dose administration to anesthetized piglets and multiple-dose administration to conscious rats Proc Natl Acad Sci USA 98 2814-2819
[27]  
Huttner WB(2002)An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis J Biol Chem 277 388-394
[28]  
O′Connor DT(2004)Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells FEBS Lett 571 107-111
[29]  
Turquier V(2004)Recycling of intact dense core vesicles in neurites of NGF-treated PC12 cells J Biol Chem 279 20096-20107
[30]  
Yon L(2007)Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells Nucleic Acids Res 35 5439-5451
12345678910